SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-022858
Filing Date
2021-02-16
Accepted
2021-02-16 07:36:04
Documents
13
Period of Report
2021-02-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm216667d3_8k.htm   iXBRL 8-K 25876
2 EXHIBIT 99.1 tm216667d3_ex99-1.htm EX-99.1 12423
  Complete submission text file 0001104659-21-022858.txt   215149

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlgt-20210215.xsd EX-101.SCH 3184
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlgt-20210215_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlgt-20210215_pre.xml EX-101.PRE 22709
6 EXTRACTED XBRL INSTANCE DOCUMENT tm216667d3_8k_htm.xml XML 3479
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 856.697.1441
Teligent, Inc. (Filer) CIK: 0000352998 (see all company filings)

IRS No.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-08568 | Film No.: 21632493
SIC: 2834 Pharmaceutical Preparations